Opinion|Videos|July 23, 2024
Empowering Patients: Key Considerations for BTK Inhibitor Adherence
A conversation on how to empower patients and the considerations for BTK inhibitor adherence.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- What are the key considerations for educating and empowering patients about BTK inhibitors to support adherence for the course of long-term treatment?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
